Welcome Guest.
Not a member yet? Why not sign up today and start posting on our forums.
Catalent seeks slice of gene therapy market with Paragon buy
#1

Catalent seeks slice of gene therapy market with Paragon buy

Contract drugmaker Catalent Inc said on Monday it would buy privately held Paragon Bioservices Inc for $1.2 billion in cash, bolstering its capabilities to make gene therapy drugs for its biotech clients.




http://feeds.reuters.com/~r/reuters/heal...SKCN1RR12F
Reply